VIR — VIR BIOTECHNOLOGY INC

Ownership history in SALZHAUER MICHAEL  ·  2 quarters on record

This page tracks every 13F SEC filing in which SALZHAUER MICHAEL reported a position in VIR BIOTECHNOLOGY INC (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.13% (2025 Q3)
Avg. % of fund
0.06%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 8,600 +4,300 +100.0% 0.00% $2K $5.71
2025 Q3 INITIATED 4,300 — — 0.13% $262K $5.71
% of Fund (quarterly)    VIR price (monthly, adj. close)

Other funds also holding VIR

As of 2025 Q4 — sorted by position size

ARCH Venture Management, LLC 3Y 7Y 11.95% GSK plc 6.45% GordonMD Global Investments LP 4.02% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 0.79% Sio Capital Management, LLC 3Y 7Y 0.45% Tejara Capital Ltd 3Y 0.33% Eagle Health Investments LP 3Y 0.32% ORBIMED ADVISORS LLC 3Y 7Y 0.29% Ikarian Capital, LLC 3Y 0.27% Clarius Group, LLC 3Y 7Y 0.21%
← Back to SALZHAUER MICHAEL Holdings